Diagnosis of tuberculosis in children

Similar documents
Diagnosis of tuberculosis in children H Simon Schaaf

Epidemiology and diagnosis of MDR-TB in children H Simon Schaaf

TB & HIV CO-INFECTION IN CHILDREN. Reené Naidoo Paediatric Infectious Diseases Broadreach Healthcare 19 April 2012

Gary Reubenson 16 October 2012 PAEDIATRIC TUBERCULOSIS: AN OVERVIEW IN 40 MINUTES!!

Dr Francis Ogaro MTRH ELDORET

TB in Children. Rene De Gama Block 10 Lectures 2012

Algorithmic Approaches to Child TB Management in Resource-limited Settings

TB: A Supplement to GP CLINICS

TB Intensive Houston, Texas. Childhood Tuberculosis Kim Connelly Smith. November 12, 2009

Tuberculosis Intensive

TB Nurse Case Management San Antonio, Texas July 18 20, 2012

Pediatric Drug-Resistant TB in China

Pediatric TB Lisa Armitige, MD, PhD September 28, 2011

GENEXPERT: TOWARDS STANDARD EVALUATION OF A TB INDEX TEST IN CHILDREN

TB in Children. The diagnostic challenge. Ralph Diedericks Red Cross Hospital

TB Nurse Case Management San Antonio, Texas March 7 9, Pediatric TB Kim Connelly Smith, MD, MPH March 8, 2012

Latent Tuberculosis Infections Controversies in Diagnosis and Management Update 2016

Diagnosis of TB in Children. Dr Jacquie Narotso Oliwa

Introduction. Diagnosis of extrapulmonaryand paediatric tuberculosis. Extrapulmonary tuberculosis EPTB SASCM WORKSHOP 2014/05/24

The Diagnosis of Active TB. Deborah McMahan, MD TB Intensive September 28, 2017

When good genes go bad

GUIDELINES FOR THE MANAGEMENT OF TUBERCULOSIS IN CHILDREN

New Tuberculosis Guidelines. Jason Stout, MD, MHS

Pediatric TB Intensive Houston, Texas October 14, 2013

The Origin of Swine Flu

Tuberculosis - clinical forms. Dr. A.Torossian,, M.D., Ph. D. Department of Respiratory Diseases

TB Intensive San Antonio, Texas May 7-10, 2013

Diagnosis and Medical Management of Latent TB Infection

New Standards for an Old Disease:

The SAARC Regional Programme Guidelines of Diagnosis & Management of Pediatric Tuberculosis (TB) 2017

of clinical laboratory diagnosis in Extra-pulmonary Tuberculosis

TB in the Patient with HIV

Report on WHO Policy Statements

Tuberculosis Intensive

TB Intensive San Antonio, Texas

Pediatric Tuberculosis Lisa Y. Armitige, MD, PhD September 14, 2017

TB Intensive San Antonio, Texas. TB/HIV Co-Infection. Lisa Armitige, MD, PhD has the following disclosures to make:

MANAGEMENT OF TUBERCULOSIS IN NEONATES AND YOUNG INFANTS

What you need to know about diagnosing and treating TB: a preventable, fatal disease. Bob Belknap M.D. Denver Public Health November 2014

TB/HIV 2 sides of the same coin. Dr. Shamma Shetye, MD Microbiology Metropolis Healthcare, Mumbai

Targeted Testing and the Diagnosis of. Latent Tuberculosis. Infection and Tuberculosis Disease

The need for new TB diagnostics in children and the way forward

Tuberculosis Tools: A Clinical Update

The Lancet Infectious Diseases

TUBERCULOSIS. Pathogenesis and Transmission

DIAGNOSIS AND MEDICAL MANAGEMENT OF TB DISEASE

Research Methods for TB Diagnostics. Kathy DeRiemer, PhD, MPH University of California, Davis Shanghai, China: May 8, 2012

TB/HIV CO-INFECTION ADULT & CHILDREN (INCLUDING INH PROPHYLAXIS) ART Treatment Guideline Training 31 st January to 4 th February, 2011

Tuberculosis in children: gaps and opportunities

At the end of this session, participants will be able to:

TB Nurse Case Management

Chapter 4 Diagnosis of Tuberculosis Disease

TB In Detroit 2011* Early TB: Smudge Sign. Who is at risk for exposure to or infection with TB? Who is at risk for TB after exposure or infection?

3/25/2012. numerous micro-organismsorganisms

INTENSIFIED TB CASE FINDING

Ken Jost, BA, has the following disclosures to make:

Diagnosis & Medical Case Management of TB Disease. Lisa Armitige, MD, PhD October 22, 2015

TB: Management in an era of multiple drug resistance. Bob Belknap M.D. Denver Public Health November 2012

Pediatric TB research Barriers and progress

Management of Pediatric Tuberculosis in New Jersey

Recognizing MDR-TB in Children. Ma. Cecilia G. Ama, MD 23 rd PIDSP Annual Convention February 2016

TB Intensive San Antonio, Texas August 7-10, 2012

Pediatric TB Radiology: It s Not Black and White Part 2

DESK GUIDE FOR DIAGNOSIS AND MANAGEMENT OF TB IN CHILDREN

Let s Talk TB A Series on Tuberculosis, A Disease That Affects Over 2 Million Indians Every Year

Latent TB, TB and the Role of the Health Department

Prospective evaluation of World Health Organization criteria to assist diagnosis of tuberculosis in children

Mycobacterial Infections: What the Primary Provider Should Know about Tuberculosis

PEDIATRIC TUBERCULOSIS. Objectives. Children are not just small adults. Pediatric Tuberculosis 1

TB 101 Disease, Clinical Assessment and Lab Testing

PEDIATRIC TUBERCULOSIS

TOG The Way Forward

Communicable Disease Control Manual Chapter 4: Tuberculosis

has the following disclosures to make:

Pulmonary TB Clinical Diagnosis

Northwestern Polytechnic University

CHAPTER 3: DEFINITION OF TERMS

What the Primary Physician Should Know about Tuberculosis. Topics for Discussion. Global Impact of TB

Global TB Burden

TB infection control: overview and importance

What the Primary Physician Should Know about Tuberculosis. Topics for Discussion. Life Cycle of M. tuberculosis

Childhood Tuberculosis Some Basic Issues. Jeffrey R. Starke, M.D. Baylor College of Medicine

Diagnosis and Medical Management of TB Disease. Quratulian Annie Kizilbash, MD, MPH March 17, 2015

11/3/2009 SECOND EDITION Madhukar Pai McGill University. ISTC Training Modules Introduction

Improved diagnosis of extrapulmonary tuberculosis by antigen detection using immunochemistry-based assay. Tehmina Mustafa

9 month old with stridor, cough, low-grade fever, mild hypoxia

INDEX CASE INFORMATION

My heart is racing. Managing Complex Cases. Case 1. Case 1

TB Update: March 2012

Disclosures. Current Issues and Controversies in Child and Adolescent Tuberculosis 02/24/2016. NSTC 2016 Annual Meeting

I. Demographic Information GENDER NUMBER OF CASES PERCENT OF CASES. Male % Female %

Mycobacteria & Tuberculosis PROF.HANAN HABIB & PROF ALI SOMILY DEPRTMENT OF PATHOLOGY, MICROBIOLOGY UNIT COLLEGE OF MEDICINE

CHAPTER:1 TUBERCULOSIS. BY Mrs. K.SHAILAJA., M. PHARM., LECTURER DEPT OF PHARMACY PRACTICE, SRM COLLEGE OF PHARMACY

Pediatric TB Theresa Barton, MD

Tuberculosis at extremes of age

PCR and direct amplification for tuberculosis diagnosis. Emmanuelle CAMBAU University Paris Diderot, APHP, Saint Louis-Lariboisière Hospital,

Diagnosis of tuberculosis

CDC IMMIGRATION REQUIREMENTS:

CULTURE OR PCR WHAT IS

Diagnosis of drug-resistant tuberculosis disease in children: A practical approach

Transcription:

Diagnosis of tuberculosis in children H Simon Schaaf Desmond Tutu TB Centre Department of Paediatrics and Child Health, Stellenbosch University, and Tygerberg Children s Hospital (TCH) Estimated TB incidence rates 2010 WHO Global TB Report 2011 1

Epidemiology ~500 000 new TB cases in South Africa/year (1% of population) Children make up 15-20% of the national TB burden Surveillance of drug resistance in adults last done in 2001, but WHO estimates 13 000 new MDR-TB cases/yr in SA, of which also ~15-20% will be in children Of concern is a rising trend also of RIF-monoresistant TB Conventional approach to TB diagnosis A constellation of the following: History of chronic symptoms and TB contact Clinical examination (incl. growth assessment) Tuberculin skin testing (or IGRAs?) Chest radiography Bacteriological confirmation Histology (especially EPTB) HIV testing (high prevalence areas or patients at risk) (Scoring systems and diagnostic algorithms) 2

Age-related risk Immune compromised History of symptoms of chronic disease Symptoms may overlap with other diseases, but welldefined symptoms give improved yield: - Chronic cough = unremitting cough >3 weeks - Fever = >7-14 days after excluding common causes - Weight loss or FTT = preferably documented on growth chart (RTHC) - Fatigue (tiredness) not keeping up with others In some children TB presents as an acute pneumonia; both in HIV-infected and -uninfected 3

Symptom characteristics 1) Acute with delayed recovery 2) Recurrent Intensity of Cough 3) Persistent, non-remittent 1w 2w 3w 4w Duration in weeks History of contact A close contact = living in the same household (or in frequent contact) with source case. Sputum smear-positive TB case > infectious than smear-negative source cases, but still infectious! Screen all children (especially <5 years or HIVinfected) in HH contact with PTB cases for TB Contact with source case is found in only 40-70% of cases. May be infected outside of household Often undiagnosed or other TB cases in the family - in infants, may be worthwhile to screen mother Find out about DST of adult source cases! 4

Clinical examination There are no specific features on clinical examination to confirm that presenting illness is due to pulmonary TB Physical signs highly suggestive of EPTB: - Gibbus, especially recent onset (spinal TB) - Non-painful cervical lymphadenopathy with fistula formation Clinical examination Physical signs requiring investigation for EPTB: Meningitis: with sub-acute onset or not responding to AB Pleural effusion older children Pericardial effusion Distended abdomen with ascites Non-painful cervical lymphadenopathy without fistula formation Signs of tuberculin hypersensitivity (phlyctenular conjunctivitis, erythema nodosum, PNT) Painful joint(s) 5

Tuberculin skin test (TST) Useful to identify children infected with TB Mantoux TST the recommended test Read in mm induration after 48-72 hours. Regarded as positive as follows: High-risk children: 5 mm (HIV-infected or severely malnourished children) All other children: 10 mm Negative TST does not rule out TB Interferon-gamma release assays Based on release of IFN-γ produced by T-cells Two blood tests commercially available - T-Spot.TB (ELISPOT) - Quantiferon-TB Gold In-tube test Diagnose infection and not disease (as TST) More specific than TST not affected by BCG IGRAs possibly more sensitive than TST, but this has not been confirmed in high-burden areas Time to lab / amount of blood / cost are limitations May be specific indications for use, but many studies still evaluating its role in children 6

Chest Radiography Remains an important tool in diagnosis although: Quality of radiographs are important Chest radiographs often misread in children with TB. Intra- and inter-observer error for hilar lymphadenopathy common Suggestive pictures Enlarged hilar and/or mediastinal lymph nodes with or without (persistent) opacification in the lung Ghon focus/complex (uncommon) Miliary pattern in HIV-uninfected children Adolescents: adult type PTB or pleural effusion HIV/TB: Chest Radiography Basic features the same. Often more difficult to interpret: HIV-associated lung conditions look similar to TB, e.g. bronchiectasis, recurrent pneumonias, LIP TB can occur concurrently with other diseases Reticulonodular (miliary) picture ± adenopathy could be miliary TB, LIP or other conditions Reports: (Madhi IJTLD 2000, Hesseling IJTLD 2002) more cavitation in HIV+ TB more miliary TB in HIV+ TB Most children with TB are not HIV-infected! 7

Other imaging (remember EPTB) Ultrasound: Abdominal TB, pleural and pericardial effusions CT scans: TBM, chest mainly MRI scans: Spinal TB, TBM Bronchoscopy: lymph nodes and its effects HIV-infected vs. non-hiv-infected There are still many more HIV-uninfected children with TB than HIV-infected Treat HIV-infected children as a high-risk group (infection is as important as disease). As immune status deteriorates (lower CD4%), risk for TB increases Early HAART will reduce risk between 3-10 times, but risk remains higher than in HIVuninfected children 8

Point Scoring System Scoring systems or diagnostic approaches Critical review of these approaches shows that few have been tested and sensitivity and specificity has not been calculated (A Hesseling et al. IJTLD 2002;6:1038-45 ) In an area with high HIV prevalence the specifity was 25% (95% CI 16-37%) (P van Rheenen. Trop Med Int Health 2002;7:435-41) In developing countries scoring systems is all that is available stepwise approach more a screening tool than a diagnostic tool 9

Contact management algorithm Child close contact of infectious PTB case 0-59 months or HIV+ >60 months & HIV- Well Symptomatic Symptomatic Well 6H Consider TB* No treatment If becomes symptomatic If becomes symptomatic *Follow guidelines for diagnosis How to investigate contacts Clinical assessment: History (Symptoms; closeness and duration of contact; drug resistance) Clinical examination Clinical assessment alone is sufficient to decide whether contact is well or symptomatic If available: TST (exposure prophylax even if TST negative) CXR (for diagnosis of disease) 10

Why do we need microbiological confirmation? The majority of child TB cases are diagnosed at primary care level without microbiological confirmation, as specimens from children are difficult to obtain and often those children have primary (paucibacillary) TB In >80% of culture-confirmed cases in hospital the diagnosis of TB was made before culture result was available If DST of adult source case is known, child contact should be treated according to adult isolate s DST result, as concordance between source case and child s isolates is between 78-90% in different studies Why do we need microbiological confirmation? To confirm TB in difficult cases, e.g. uncertain lung pathology, HIV-infected children, extrapulmonary TB To determine drug susceptibility in children with unknown source cases, especially if they have poor response to first-line treatment To confirm drug resistance if a source case with DR-TB is identified in our experience up to 20% not the same DST pattern as source case, either because different source case or infected before amplification of resistance in the source case 11

Culture for M. tuberculosis Only 5-10% smear-positive yield in children Cultures positive in 30-40% of hospital-based cases; lower in community-based studies. Respiratory samples in children: Induced sputum ~ gastric aspirate NPA, tracheal aspirates or BAL FNA biopsies are useful for diagnosis of EPTB Any other body fluid/biopsy of tissue suspected of TB (e.g. CSF, bone/sinovial biopsy) Progress in the role-out of Xpert MTB/RIF, as of June 2011 WHO Global TB Report 2011 12

GeneXpert MTB/RIF GXP PCR-based diagnosis of both M.tuberculosis complex as well as RIF resistance. Becoming more of point-of-care test and replacing sputum smear microscopy, but culture still needs to be done to confirm results and, in case of RIF resistance, to confirm MDR- TB and do second-line DST Mainly done on sputum samples, but several studies have shown its value also with other specimens, e.g. GA, FNA from lymph nodes DST in children Culture & DST takes longer but provides best yield (30-70% in symptomatic children). Phenotypic or genotypic DST can be done, the latter providing more rapid results Xpert MTB/RIF should in children be followed by culture and DST, because children usually have smear-negative disease, and only ~60% of smear-neg, culture-pos cases will be identified. Xpert MTB/RIF also does not provide further DST results other than RIF (currently mainly sputum used) With increasing RIF-monoresistant TB cases in adults and Xpert MTB/RIFresults only, managing child contacts becomes a problem 13

Line Probe Assays Line-probe assays, a family of DNA strip-based tests that use PCR and reverse hybridization methods for the rapid detection of mutations associated with drug resistance, are available as commercial kits. Confirms M. tuberculosis complex and provides drug susceptibility test (DST) results for INH and RIF GenoType MTBDRplus INH and RIF mutations GenoType MTBDRsl second-line drugs Problems: Need laboratory set-up, risk of cross contamination Advantage: identifies the mutation conferring resistance to INH. This could assist with choosing the correct drugs, e.g. high-dose INH vs ethionamide Conclusion of present data There is very little new data that has dramatically changed our ability to diagnose TB in children The more proof, the more certain the diagnosis Scoring systems, despite its shortcomings may still have a role to play as a screening tool in certain settings Younger children are at greater risk for complications e.g. disseminated TB and TBM, therefore treat earlier Role of culture/dst confirming diagnosis and identification & confirmation of drug resistance 14